GlassScriptPhysician profile
Jesse Pullen Penico
NPI 1912904590
$49,410.04
in general payments reported to CMS, 2019-2025
31 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $7,985 · 2020: $8,201 · 2021: $27K · 2022: $6,190.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Paratek Pharmaceuticals, INC. | $41,680.33 | 2019-2022 | |
| Viiv Healthcare Company | $1,616.43 | 2019-2022 | |
| La Jolla Pharmaceutical Company | $1,361.52 | 2020-2022 | |
| Astellas Pharma US INC | $657.97 | 2019-2022 | |
| Merck Sharp & Dohme LLC | $628.07 | 2019-2022 | |
| Gilead Sciences, INC. | $594.12 | 2019-2022 | |
| Insmed, INC. | $504.04 | 2019-2022 | |
| Abbvie INC. | $399.03 | 2019-2021 | |
| Janssen Biotech, INC. | $316.87 | 2019-2021 | |
| Melinta Therapeutics, LLC | $316.19 | 2019-2021 | |
| Accelerate Diagnostics INC. | $277.75 | 2019-2022 | |
| Cumberland Pharmaceuticals, INC. | $245.11 | 2019-2021 | |
| Tetraphase Pharmaceuticals, INC. | $208.62 | 2019-2020 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $161.11 | 2019-2022 | |
| Theratechnologies INC. | $70.41 | 2019-2021 |
Show all 31 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Takeda Pharmaceuticals U.S.A., INC. | $67.48 | 2019-2022 | |
| Emd Serono, INC. | $36.26 | 2019 | |
| Intercept Pharmaceuticals, INC. | $30.76 | 2019 | |
| Janssen Pharmaceuticals, INC | $28.48 | 2021 | |
| Pfizer INC. | $28.10 | 2021 | |
| Allergan, INC. | $26.61 | 2019-2020 | |
| Dova Pharmaceuticals | $24.66 | 2019 | |
| Mayne Pharma Commercial LLC | $22.52 | 2022 | |
| Seqirus USA INC | $16.92 | 2019 | |
| Alnylam Pharmaceuticals INC. | $15.82 | 2022 | |
| Shire North American Group INC | $15.13 | 2019 | |
| Shionogi INC | $14.52 | 2021 | |
| Braintree Laboratories, INC. | $13.28 | 2021 | |
| Nestle Healthcare Nutrition INC. | $12.61 | 2022 | |
| Daiichi Sankyo INC. | $11.22 | 2020 | |
| Advanced Oxygen Therapy INC. | $8.10 | 2020 |
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jesse Penico listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.